Drug shortage
Clindamycin Phosphate Injection · Sagent Pharmaceuticals
FDA drug shortage · Current · updated Sep 18, 2026
Key facts
| Generic name | Clindamycin Phosphate Injection |
|---|---|
| Company | Sagent Pharmaceuticals |
| Presentation | Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06) |
| Dosage form | Injection |
| Status | Current |
| Reason for shortage | Discontinuation of the manufacture of the drug |
| Therapeutic category | Anti-Infective |
| Package NDCs | 25021-115-06 |
| First posted | Mar 21, 2023 |
| Last updated | Sep 18, 2026 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: